Adrian Hargrave, CEO of SEEEN, explains how the Company is now funded through to profitability.  Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNTA.L Regulatory News (NTA)

  • There is currently no data for NTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Northacre PLC))

31 Dec 2012 07:00

RNS Number : 5045U
Northacre PLC
31 December 2012
 



31 December 2012

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Northacre PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Northacre PLC

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEREE

(e) Date position held:

20 December 2012

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

None

(2) Derivatives (other than options):

None

(3) Options and agreements to purchase/sell:

None

 

TOTAL:

None

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

-

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

Northacre has appointed a committee of Independent Directors to review any potential offers for the Company. As such, the only directors deemed to be acting in concert with Northacre are the independent directors, Brian Harris and Malcolm Williams.

 

Directors

Nominee or connected party

Holding

% of issued capital

Brian Harris

(independent director)

Nil

-

Malcolm Williams

(independent director)

Nil

-

Connected Advisers

Ernst & Young LLP

(Rule 3 adviser)

-

Nil

-

KMB Peel Hunt Limited

(Nomad and broker)

Peel Hunt Holdings Limited (market maker)

30,596

0.11

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

28 December 2012

Contact name:

Duncan Salmon

Telephone number:

020 7427 6400

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEBKCDNOBDDDBB
Date   Source Headline
5th Jan 20175:12 pmRNSHolding(s) in Company
4th Jan 201712:39 pmRNSResult of GM and Cancellation of Admission
9th Dec 20161:00 pmRNSProposed Cancellation of Admission & Notice of GM
21st Oct 20162:44 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSInterim Results
9th Jun 201612:14 pmRNSResult of Annual General Meeting
29th Apr 20162:00 pmRNSFinal Results
24th Feb 20169:00 amRNSPlanning Permission Approved
3rd Nov 20153:00 pmRNSDirectorate Change
15th Sep 20157:00 amRNSInterim Results
19th Jun 201510:19 amRNSAppointment as Development Manager
2nd Jun 20152:13 pmRNSResult of AGM
30th Apr 20152:00 pmRNSFinal Results
12th Nov 20143:20 pmRNSPlanning permission granted
11th Nov 20142:00 pmRNSInterim Results
8th Sep 20142:34 pmRNSResult of General Meeting
26th Aug 20142:03 pmRNSResult of AGM
14th Aug 20144:25 pmRNSCircular, Dividend and Withdrawal of Resolutions
13th Aug 20147:00 amRNSRe Consultancy Agreement
1st Aug 201412:54 pmRNSAcquisition of Development Project
14th Jul 20147:00 amRNSResults for the year ended 28 February 2014
25th Jun 20147:00 amRNSSale of Development Project
29th May 20147:00 amRNSAppointment as Development Manager
19th May 20142:30 pmRNSChange of Accounting Reference Date
23rd Apr 20143:26 pmRNSAppointment as Development Manager
14th Apr 20147:00 amRNSTrading Update
19th Feb 20147:00 amRNSAppointment as Development Manager
11th Feb 20147:00 amRNSDirectorate Change
9th Jan 20147:00 amRNSHolding(s) in Company
8th Jan 20141:00 pmRNSAppointment as Development Manager
23rd Dec 201311:57 amRNSResult of GM and Open Offer
17th Dec 20139:57 amRNSThe Lancasters update
5th Dec 20137:00 amRNSProposed Open Offer and Cash Box Acquisition
19th Nov 20137:00 amRNSResults for the six months ended 31st August 2013
18th Sep 20137:00 amRNSCommitment to Invest
22nd Aug 20133:21 pmRNSAcquisition of Development Project
21st Aug 20137:00 amRNSDirectorate Change
19th Aug 20135:20 pmRNSResult of AGM
12th Jul 20131:46 pmRNSAnnual Financial Report and notice of AGM
5th Jul 201311:35 amRNSReceipt of Dividend and Update on the Lancasters
4th Jul 20135:36 pmRNSDividend Declaration
3rd Jul 201310:30 amRNSAppointment of Director
27th Jun 201311:43 amRNSConsultancy Agreement
25th Jun 201311:04 amRNSDirectorate Change
19th Jun 20134:30 pmRNSDirectorate Change
8th Apr 20134:25 pmRNSReceipt of Dividend and Update on The Lancasters
8th Apr 20137:00 amRNSChange of Adviser
28th Mar 20131:19 pmRNSDirectorate & Corporate Change
15th Mar 20137:00 amRNSOffer Closed
1st Mar 20137:00 amRNSFirst and Final Closing Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.